See more : Hess Corporation (0J50.L) Income Statement Analysis – Financial Results
Complete financial analysis of The Joint Corp. (JYNT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Joint Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- AP Acquisition Corp. (APCA-UN) Income Statement Analysis – Financial Results
- Aura Energy Limited (AURA.L) Income Statement Analysis – Financial Results
- PT Duta Intidaya Tbk (DAYA.JK) Income Statement Analysis – Financial Results
- PT. Map Boga Adiperkasa Tbk (MAPB.JK) Income Statement Analysis – Financial Results
- U.S. Bancorp PERP PFD SER A (USB-PA) Income Statement Analysis – Financial Results
The Joint Corp. (JYNT)
About The Joint Corp.
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 117.70M | 101.91M | 81.19M | 58.68M | 48.45M | 31.79M | 25.16M | 20.52M | 13.84M | 7.12M | 5.96M | 2.78M |
| Cost of Revenue | 10.55M | 9.83M | 8.51M | 6.51M | 5.57M | 4.31M | 3.31M | 2.94M | 2.82M | 2.25M | 2.01M | 1.09M |
| Gross Profit | 107.15M | 92.08M | 72.68M | 52.18M | 42.88M | 27.48M | 21.85M | 17.58M | 11.02M | 4.87M | 3.95M | 1.69M |
| Gross Profit Ratio | 91.04% | 90.35% | 89.51% | 88.91% | 88.51% | 86.44% | 86.84% | 85.68% | 79.62% | 68.43% | 66.33% | 60.84% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 343.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 81.47M | 67.99M | 49.12M | 36.20M | 30.54M | 20.30M | 18.12M | 22.10M | 15.37M | 5.10M | 2.66M | 2.24M |
| Selling & Marketing | 16.54M | 13.96M | 11.42M | 7.80M | 6.91M | 4.82M | 4.47M | 4.42M | 3.69M | 1.19M | 781.26K | 748.92K |
| SG&A | 98.01M | 81.95M | 60.55M | 44.00M | 37.46M | 25.12M | 22.59M | 26.52M | 19.06M | 6.29M | 3.44M | 2.99M |
| Other Expenses | 11.21M | 7.64M | 6.09M | 2.73M | 1.90M | -47.77K | -64.46K | 13.30K | 22.12K | -64.08K | -32.00K | 36.32K |
| Operating Expenses | 109.22M | 89.59M | 66.64M | 46.73M | 39.36M | 26.68M | 24.61M | 29.09M | 20.33M | 6.50M | 3.51M | 3.04M |
| Cost & Expenses | 119.77M | 99.42M | 75.15M | 53.24M | 44.92M | 30.99M | 27.92M | 32.03M | 23.15M | 8.74M | 5.52M | 4.13M |
| Interest Income | 0.00 | 133.10K | 69.88K | 79.48K | 61.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 67.46K | 953.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 8.58M | 6.65M | 6.09M | 2.73M | 1.90M | 1.56M | 2.02M | 2.57M | 1.27M | 210.12K | 70.73K | 49.81K |
| EBITDA | 9.14M | 7.89M | 12.16M | 8.18M | 5.43M | 2.29M | -896.78K | -8.85M | -7.76M | -1.42M | 510.51K | -1.30M |
| EBITDA Ratio | 7.77% | 10.34% | 14.98% | 13.84% | 11.40% | 9.10% | -1.28% | -26.39% | -60.05% | -19.91% | 8.57% | -46.58% |
| Operating Income | -2.07M | 2.90M | 6.01M | 5.49M | 3.41M | 205.11K | -3.17M | -15.02M | -9.32M | -1.63M | 439.79K | -1.35M |
| Operating Income Ratio | -1.76% | 2.84% | 7.40% | 9.36% | 7.05% | 0.65% | -12.62% | -73.20% | -67.34% | -22.86% | 7.38% | -48.37% |
| Total Other Income/Expenses | 3.71M | -133.10K | -187.33K | -79.48K | -42.22K | -33.59K | -64.46K | -1.47K | 283.27K | -64.08K | -32.00K | 36.32K |
| Income Before Tax | 1.64M | 1.94M | 5.94M | 5.41M | 3.37M | 215.36K | -3.24M | -15.01M | -9.03M | -1.69M | 407.79K | -1.31M |
| Income Before Tax Ratio | 1.39% | 1.91% | 7.31% | 9.22% | 6.96% | 0.68% | -12.87% | -73.13% | -65.29% | -23.76% | 6.84% | -47.07% |
| Income Tax Expense | 11.39M | 766.51K | -1.22M | -7.75M | 48.71K | -37.73K | 35.88K | 164.43K | -235.86K | 1.34M | 252.15K | -574.53K |
| Net Income | -9.75M | 1.18M | 7.57M | 13.17M | 3.32M | 253.08K | -3.28M | -15.17M | -8.80M | -3.03M | 155.64K | -736.30K |
| Net Income Ratio | -8.29% | 1.16% | 9.32% | 22.44% | 6.86% | 0.80% | -13.02% | -73.93% | -63.59% | -42.59% | 2.61% | -26.44% |
| EPS | -0.66 | 0.08 | 0.46 | 0.94 | 0.24 | 0.02 | -0.25 | -1.20 | -0.88 | -0.56 | 0.02 | -0.08 |
| EPS Diluted | -0.66 | 0.08 | 0.44 | 0.90 | 0.23 | 0.02 | -0.25 | -1.20 | -0.88 | -0.56 | 0.02 | -0.08 |
| Weighted Avg Shares Out | 14.69M | 14.49M | 14.32M | 14.00M | 13.82M | 13.67M | 13.20M | 12.64M | 10.00M | 5.41M | 9.17M | 9.17M |
| Weighted Avg Shares Out (Dil) | 14.69M | 14.87M | 14.94M | 14.58M | 14.47M | 14.03M | 13.25M | 12.70M | 10.04M | 5.45M | 9.17M | 9.17M |
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi" or the "Company") (NASDAQ:KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or...
Apollo Biowellness, Inc. Announces Joint Venture/Partnership with Reveal Lasers LLC for Expanded Distribution and Collaboration of Evo Bio Products.
North Bergen, New Jersey--(Newsfile Corp. - October 31, 2024) - Apollo Biowellness, Inc. (OTC Pink: KOAN) is pleased to announce a joint venture and distribution partnership with Reveal Lasers LLC to expand the reach of Evolutionary Biologics, Inc.'s biologic products...
Standard Uranium Provides Exploration Update Highlighting Successful Project Generation with New Joint Venture Ready Projects Available in 2025
Vancouver, British Columbia--(Newsfile Corp. - October 31, 2024) - Standard Uranium Ltd. (TSXV: STND) (OTCQB: STTDF) (FSE: 9SU0) ("Standard Uranium" or the "Company")is pleased to provide a summary of work programs on three of it's 100% owned uranium exploration projects...
Tutor Perini-Nan Joint Venture Awarded $330.6 Million Apra Harbor Waterfront Repairs Project in Guam
LOS ANGELES--(BUSINESS WIRE)-- #newaward--Tutor Perini Corporation (NYSE: TPC) (the “Company”), a leading civil, building and specialty construction company, announced today that the Company, in a joint venture with Nan, Inc., has been awarded a contract with a base value of...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi" or the "Company") (NASDAQ:KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or...
The Joint Chiropractic is Named the Official Chiropractor of Grand Canyon University Athletics
SCOTTSDALE, Ariz. , Oct. 29, 2024 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, announces its newest sponsorship agreement with Grand Canyon University Athletics.
Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
Award from Medical Tech Outlook Highlights Monogram's mBôs TKA System AUSTIN, TX / ACCESSWIRE / October 29, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
NEW YORK, NY / ACCESSWIRE / October 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi" or the "Company") (NASDAQ:KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or...
Rosen Law Firm Encourages Joint Stock Company Kaspi.kz Investors to Inquire About Securities Class Action Investigation - KSPI
NEW YORK, Oct. 27, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) resulting from allegations that Kaspi.kz may...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
NEW YORK , Oct. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi" or the "Company") (NASDAQ: KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Source: https://incomestatements.info
Category: Stock Reports